Published in Br Med J on May 24, 1969
Precancerous conditions of the oral mucosa. A computer-aided study. Ann R Coll Surg Engl (1969) 2.71
Oestrogen as a reticuloendothelial stimulant in patients with cancer. Br Med J (1971) 2.14
Approaches to the immunological treatment of cancer in man. Br Med J (1969) 1.76
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J (1970) 1.59
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Prospects for immunotherapy of cancer: experience in experimental systems. Br Med J (1970) 1.11
The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer (1972) 1.08
Survival in bronchial carcinoma. Tumour remaining in the bronchial stump following resection. Ann R Coll Surg Engl (1972) 1.06
Immunology of bronchial carcinoma. Thorax (1976) 0.98
The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch (1972) 0.86
Tumour immunology and the gut. Gut (1975) 0.84
Immunological aspects of reticulum cell neoplasia. Br Med J (1970) 0.80
Transience of immune responses to tumour antigens in man. Br Med J (1971) 0.76
The role of circulating antibody in the control of metastases. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.75
Antilymphocytic serum and tumour transplantation in the brain. Acta Neuropathol (1971) 0.75
A Century of Radiation Therapy and Adaptive Immunity. Front Immunol (2017) 0.75
Cancer of the breast. Treatment of the advanced disease. Br Med J (1970) 0.75
No cell is an iland intire of it selfe. Br Med J (1969) 0.75
Necrosis of malignant melanomas of the choroid. Trans Am Ophthalmol Soc (1969) 0.75
How relevant is present cancer research? Br Med J (1969) 0.75
Antigens in human sarcomas and melanomas. Br Med J (1969) 0.75
A physiological study of the isolated spleen. Ann R Coll Surg Engl (1969) 0.75
Immunological factors in cysts of the jaws. Proc R Soc Med (1971) 0.75
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet (1964) 14.21
Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst (1957) 10.10
Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A (1968) 8.67
Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J Virol (1967) 8.29
Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer (1966) 4.85
Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet (1955) 4.55
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
IMMUNOLOGY OF EXPERIMENTAL TUMORS. Annu Rev Med (1964) 4.20
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
The role of the reticuloendothelial system in the host reaction to neoplasia. Cancer Res (1961) 3.86
Inhibition of tumour growth by administration of killed corynebacterium parvum. Nature (1966) 3.81
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A (1966) 3.56
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Spontaneous regression of cancer: preliminary report. Ann Surg (1956) 3.49
AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYS. Lancet (1964) 3.45
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
Leukaemogens. Lancet (1958) 3.17
Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer (1968) 3.16
Possible immunological factors in human malignant melanoma in Uganda. Lancet (1967) 3.16
Immunopathology of New Zealand black (NZB) mice. Transplantation (1965) 3.06
Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood (1963) 3.03
Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med (1968) 3.01
Determining the climatic limitations of a children's cancer common in Africa. Br Med J (1962) 3.00
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Immunological aspects of malignant disease. Lancet (1967) 2.66
AN EPIDEMIOLOGIC APPROACH TO THE LYMPHOMAS OF AFRICAN CHILDREN AND BURKITT'S SACROMA OF THE JAWS. Perspect Biol Med (1964) 2.56
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J (1968) 2.52
Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells. J Bacteriol (1966) 2.42
THE AFRICAN LYMPHOMA: PRELIMINARY OBSERVATIONS ON RESPONSE TO THERAPY. Cancer (1965) 2.35
A study of 650 observed malignant melanomas in the South-West region. Ann R Coll Surg Engl (1968) 2.32
Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor. Cancer Res (1966) 2.16
Spontaneous regression of tumours. Clin Radiol (1962) 2.15
Sinus histiocytosis of lymph nodes in cancer. Surg Gynecol Obstet (1958) 2.13
Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A (1968) 2.12
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
RATIONALE OF SIMPLE MASTECTOMY WITHOUT RADIATION FOR CLINICAL STAGE 1 CANCER OF THE BREAST. Surg Gynecol Obstet (1965) 2.06
The auto-immune hemolytic anemia of malignant lymphocytic disease. Blood (1955) 2.02
Protective activity of fractions of tubercle bacilli against isologous tumours in mice. Nature (1961) 2.00
PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS. Lancet (1963) 1.94
AN ASSOCIATION BETWEEN THE RHEUMATIC DISEASES AND THE RETICULOSES. Ann Rheum Dis (1964) 1.93
Evidence for an immunological reaction of the host directed against its own actively growing primary tumor. J Natl Cancer Inst (1966) 1.83
CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA. JAMA (1965) 1.77
Lymphoid tissue abnormalities associated with ataxia-telangiectasia. Am J Med (1966) 1.69
Homotransplantation of human cell lines. Science (1957) 1.67
The effect of isoantibodies in vivo on three different transplantable neoplasms in mice. Cancer Res (1959) 1.64
ANTIGENIC PROPERTIES OF HUMAN TUMOURS: DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS. Br Med J (1964) 1.48
Attempted treatment of a patient with chorioncarcinoma by immunization with her husband's cells. J Obstet Gynaecol Br Emp (1958) 1.48
Comparative effect of two strains of C. parvum on phagocytic activity and tumour growth. Nature (1968) 1.47
Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes. Ann Surg (1966) 1.29
Infectious mononucleosis: detection of herpeslike virus and reticular aggregates of small cytoplasmic particles in continuous lymphoid cell lines derived from peripheral blood. Proc Natl Acad Sci U S A (1968) 1.28
Effect of nucleic acids from immune lymphocytes on rat sarcomata. Nature (1967) 1.27
Cortisone and skin sensitivity to tuberculin in reticuloses. Br Med J (1960) 1.25
Lymphoid cells in Hodgkin's disease. Nature (1967) 1.23
Evidence of immunological reactions to autochthonous cancer in man. Eur J Cancer (1965) 1.23
Relation between cancer and congenital defects: an epidemiologic evaluation. J Natl Cancer Inst (1968) 1.22
The effect of vaccine on cancer patients. Surg Gynecol Obstet (1959) 1.21
Long-term survivors in acute leukemia and Burkitt's tumor. Cancer (1968) 1.18
Electron microscopic studies of human leukemia and lymphoma. Cancer (1967) 1.17
Autoimmunity and malignancy in New Zealand black mice. Proc R Soc Med (1967) 1.13
DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS. Ann N Y Acad Sci (1964) 1.13
A new method of active immunisation to autologous human tumour tissue. Lancet (1967) 1.12
HODGKIN'S DISEASE. PROGNOSIS AND RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGE. JAMA (1964) 1.11
VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA. Cancer (1964) 1.10
Structural representations of tumor-host relationships in gastric carcinoma. Surg Gynecol Obstet (1956) 1.09
Virus in cultured lymphoblasts from a New Guinea Burkitt lymphoma. Br Med J (1967) 1.07
FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT. Cancer (1965) 1.03
AUTOTRANSPLANTATION OF HUMAN CANCER. JAMA (1965) 1.03
Attempted adoptive immunotherapy of acute leukaemia by leucocyte transfusions. Lancet (1966) 1.02
Attempts to induce immunity against mammary adenocarcinoma in inbred mice. Cancer Res (1953) 0.99
Immunotherapy of a patient with choriocarcinoma. Can Med Assoc J (1961) 0.98
The experimental local therapy of cutaneous metastases of malignant melanoblastomas with cow pox vaccine or colcemid (demecolcine or omaine). Aust J Dermatol (1961) 0.98
Tumours of the testicle. Br J Radiol (1957) 0.91
Evidence for viruses in acute leukemia and Burkitt's tumor. Cancer (1968) 0.91
Antibodies against human leukemia cell lines. J Immunol (1967) 0.90
IMMUNITY AND THE TREATMENT OF CANCER. Lancet (1964) 0.83
The immunological reactivity of patients with cancer: a preliminary report. Can Med Assoc J (1990) 0.83
African lymphoma. Observations on response to vincristine sulphate therapy. Cancer (1966) 0.82
TESTICULAR SEMINOMA. A REVIEW OF 179 PATIENTS TREATED OVER A 50-YEAR PERIOD. Arch Surg (1965) 0.81
Host defences to Burkitt tumour. Br Med J (1967) 0.80
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Management of adult acute myelogenous leukaemia. Br Med J (1973) 3.33
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J (1971) 2.82
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Br Med J (1970) 2.51
Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J (1971) 2.50
Lymphoid cellular responses in the blood after immunization in man. J Exp Med (1969) 2.25
Combination chemotherapy in generalized Hodgkin's disease. Br Med J (1970) 1.67
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J (1970) 1.39
Significance of the changes in the circulating lymphoid cells in Hodgkin's disease. Br Med J (1969) 1.35
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Acute leukemia in adults. Semin Hematol (1974) 1.28
Lymphoid cells in Hodgkin's disease. Nature (1967) 1.23
Cellular resistance to tumours. Br Med Bull (1967) 1.22
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
Evidence for antigenicity in human tumours with reference to both melanoma and acute leukaemia. Br Med J (1970) 1.00
Hypoplastic acute myelogenous leukaemia. Br J Haematol (1975) 0.95
Treatment of polycythaemia vera. Br Med J (1967) 0.86
Changes in the lymphoid cell population of peripheral blood in man during immune responses. Br J Haematol (1968) 0.84
Desoxyribonucleic acid synthesis in the lymphocytes of patients with malignant disease. Eur J Cancer (1967) 0.83
Human resistance to tumours. Proc R Soc Med (1967) 0.78
Circulating lymphoid cells in Hodgkin's disease. Natl Cancer Inst Monogr (1973) 0.78
Detection of tumor specific immune reactions in human melanoma. Ann N Y Acad Sci (1971) 0.77
Leukemias and lymphomas. Semin Hematol (1974) 0.77
Immunotherapy for acute myelogenous leukemia. Bibl Haematol (1975) 0.76
Evidence for antigenicity in human tumours with reference both to melanoma and acute leukemia. Proc R Soc Med (1971) 0.75
Chemotherapy of Hodgkin's Disease with Cyclophosphamide, Vinblastine, and Procarbazine. Br Med J (1966) 0.75
Hodgkin's disease. Nurs Times (1967) 0.75
Inhibitation by L-asparaginase from E. coli of human malignant melanoma cells growing in vitro. Recent Results Cancer Res (1970) 0.75
Autoantibodies in malignant disease. Br J Haematol (1972) 0.75
The treatment of Hodgkin's disease. Trans Med Soc Lond (1972) 0.75
Blood and neoplastic diseases. Treatment of the lymphomas. Br Med J (1974) 0.75
Immunity in malignant disease. Trans Med Soc Lond (1968) 0.75
The use of different drugs and combinations in the treatment of Hodgkin's disease. Ser Haematol (1973) 0.75
Letter: Repeated acupunctures and serum hepatitis. Br Med J (1974) 0.75
The place of combination chemotherapy in the treatment of malignant disease. Br J Radiol (1973) 0.75
The periodic acid-Schiff reaction of lymphocytes in human malignant disease. Br J Haematol (1969) 0.75
Blast crisis of chronic myeloid leukaemia: the effect of intensive chemotherapy. Scand J Haematol (1976) 0.75
The treatment of acute myeloblastic leukaemia. Br J Haematol (1971) 0.75
Combination chemotherapy in malignant diseases. J R Coll Physicians Lond (1971) 0.75
Changes in the lymphoid cells of the peripheral blood in Hodgkin's disease. Br J Haematol (1968) 0.75
Smooth muscle antibody in malignant disease. Nouv Rev Fr Hematol (1973) 0.75
Immunity to malignant disease in man. Minerva Pediatr (1971) 0.75
Immunity to malignant disease in man. Sci Basis Med Annu Rev (1971) 0.75
Immunotherapy in the management of myelogenous leukemia. Arch Intern Med (1976) 0.75